IDEXX Laboratories Inc (IDXX)
494.42
+0.56
(+0.11%)
USD |
NASDAQ |
Apr 24, 16:00
495.29
+0.86
(+0.17%)
After-Hours: 19:15
IDEXX Laboratories Cash from Investing (Quarterly): -30.44M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.44M |
| September 30, 2023 | -27.84M |
| June 30, 2023 | -27.47M |
| March 31, 2023 | -39.51M |
| December 31, 2022 | -49.23M |
| September 30, 2022 | -49.20M |
| June 30, 2022 | -55.09M |
| March 31, 2022 | -41.84M |
| December 31, 2021 | -44.04M |
| September 30, 2021 | -49.68M |
| June 30, 2021 | -174.66M |
| March 31, 2021 | -24.59M |
| December 31, 2020 | -15.69M |
| September 30, 2020 | -19.46M |
| June 30, 2020 | -24.56M |
| March 31, 2020 | -49.67M |
| December 31, 2019 | -95.91M |
| September 30, 2019 | -37.33M |
| June 30, 2019 | -34.08M |
| March 31, 2019 | -38.21M |
| December 31, 2018 | -39.84M |
| September 30, 2018 | -54.22M |
| June 30, 2018 | -27.65M |
| March 31, 2018 | 260.31M |
| December 31, 2017 | -24.49M |
| Date | Value |
|---|---|
| September 30, 2017 | -41.49M |
| June 30, 2017 | -43.70M |
| March 31, 2017 | -29.01M |
| December 31, 2016 | -14.28M |
| September 30, 2016 | -22.95M |
| June 30, 2016 | -29.76M |
| March 31, 2016 | -23.80M |
| December 31, 2015 | -26.01M |
| September 30, 2015 | -54.81M |
| June 30, 2015 | -66.97M |
| March 31, 2015 | -160.62M |
| December 31, 2014 | -35.62M |
| September 30, 2014 | -23.45M |
| June 30, 2014 | -8.712M |
| March 31, 2014 | -12.63M |
| December 31, 2013 | -16.98M |
| September 30, 2013 | -25.74M |
| June 30, 2013 | -26.05M |
| March 31, 2013 | -17.29M |
| December 31, 2012 | -17.05M |
| September 30, 2012 | -18.93M |
| June 30, 2012 | -14.81M |
| March 31, 2012 | -7.344M |
| December 31, 2011 | -54.90M |
| September 30, 2011 | -16.35M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-174.66M
Minimum
Jun 2021
-15.69M
Maximum
Dec 2020
-46.86M
Average
-39.51M
Median
Mar 2023
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -152.00M |
| Haemonetics Corp | -268.94M |
| Align Technology Inc | -13.32M |
| Edwards Lifesciences Corp | 14.10M |
| ACADIA Pharmaceuticals Inc | -0.347M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 249.85M |
| Cash from Financing (Quarterly) | -101.84M |
| Free Cash Flow | 772.88M |
| Free Cash Flow Per Share (Quarterly) | 2.589 |
| Free Cash Flow to Equity (Quarterly) | 288.22M |
| Free Cash Flow to Firm (Quarterly) | 221.87M |
| Free Cash Flow Yield | 1.86% |